Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2021 | Highlights from SABCS 2021

Michael Gnant • 8 Dec 2021
SABCS 2021
Breast Cancer

Michael Gnant, MD, Medical University of Vienna, Vienna, Austria, discusses the San Antonio Breast Cancer Symposium including updates on key clinical trials in breast cancer, as well as advances in the use of molecular profiling for the management of patients with breast cancer. This interview took place at the San Antonio Breast Cancer Symposium 2021 in San Antonio.

More from Michael Gnant

5:07
What is the role of CDK4/6 inhibitors in early breast cancer?
Michael Gnant • 6 Jun 2023
2:27
NeoALTTO: HER2/CEP17 ratio as a predictive biomarker in HER2+ breast cancer
Michael Gnant • 8 Jun 2023
7:05
Late recurrences in ER-positive breast cancer and the challenges it poses for treatment
Michael Gnant • 8 Jun 2023
3:42
RxPONDER: is it all OFS?
Michael Gnant • 8 Dec 2021

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
1:26
The clinical applications of MRD in breast cancer
Mitchell Elliott • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals